| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/01/2011 | US20110212925 Novel compounds as receptor modulators with therapeutic utility |
| 09/01/2011 | US20110212900 Method for prophylactic and/or therapeutic treatment of pain associated with hematopoietic cell transplantation |
| 09/01/2011 | US20110212184 Ultra Fine Dead Sea Mineral Compound and Method of Manufacture |
| 09/01/2011 | US20110212170 Formulation For Retinoid-Containing Soft Gelatin Capsules |
| 09/01/2011 | US20110212169 METHOD FOR PRODUCING POWDER CONTAINING NANOPARTICULATED SPARINGLY SOLUBLE DRUG, POWDER PRODUCED THEREBY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME (As Amended) |
| 09/01/2011 | US20110212165 Pharmaceutical compositions of the isolated d-enantiomer of the quinazolinone derivative halofuginone |
| 09/01/2011 | US20110212164 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 09/01/2011 | US20110212135 Oligodeoxynucleotide and its use to induce an immune response |
| 09/01/2011 | US20110212133 Novel Methods of Diagnosis and Treatment of P. Aeruginosa Infection and Reagents Therefor |
| 09/01/2011 | US20110212129 Method for Producing the Flu Virus |
| 09/01/2011 | US20110212126 Inactivated chimeric vaccines and related methods of use |
| 09/01/2011 | US20110212125 Vaccine for shigella |
| 09/01/2011 | US20110212123 Immunogenic Substances Comprising a Polyinosinic Acid - Polycytidilic Acid Based Adjuvant |
| 09/01/2011 | US20110212120 Ykur polynucleotides and polypeptides |
| 09/01/2011 | US20110212117 Influenza hemagglutinin and neuraminidase variants |
| 09/01/2011 | US20110212116 Immunogenic peptides and uses thereof |
| 09/01/2011 | US20110212115 Melk epitope peptides and vaccines containing the same |
| 09/01/2011 | US20110212106 Hiv-1 neutralizing antibodies and uses thereof |
| 09/01/2011 | US20110212100 Methods for modulating development and expansion of il-17 expressing cells |
| 09/01/2011 | US20110212099 Methods of modulating il-22 and il-17 |
| 09/01/2011 | US20110212094 Dual variable domain immunoglobulins and uses thereof |
| 09/01/2011 | US20110212091 Materials and methods for inhibiting cancer cell invasion |
| 09/01/2011 | US20110212088 Anti-paf antibodies |
| 09/01/2011 | US20110212087 Antibody Fc Mutants with Ablated Effector Functions |
| 09/01/2011 | US20110212084 Binding members for ige molecules |
| 09/01/2011 | US20110212079 Adaptive biochemical signatures |
| 09/01/2011 | US20110212076 Viral Therapeutic |
| 09/01/2011 | US20110212074 Myeloid colony stimulating factor and uses thereof |
| 09/01/2011 | US20110212071 Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment |
| 09/01/2011 | US20110212053 Phosphatidylinositol 3 kinase inhibitors |
| 09/01/2011 | US20110212052 Methods and compositions of treating and preventing autoimmune diseases |
| 09/01/2011 | US20110212051 Variants of vascular endothelial growth factor (vegf) receptor and use thereof |
| 09/01/2011 | US20110212023 TADG-15: an extracellular serine protease overexpossed in carcinomas |
| 09/01/2011 | CA2790922A1 Method for preparing regulatory dentritic cells |
| 09/01/2011 | CA2790818A1 Modulation of cytokine-induced chronic inflammatory responses |
| 09/01/2011 | CA2790646A1 Silicon-containing biodegradable material for anti-inflammatory therapy |
| 09/01/2011 | CA2790013A1 Fully human anti-tnf-.alpha. monoclonal antibody, preparation method and use thereof |
| 09/01/2011 | CA2789132A1 Antagonist il-7 receptor antibodies to treat type 2 diabetes and immunological disorders |
| 08/31/2011 | EP2361981A1 RNA sequence-specific mediators of RNA interference |
| 08/31/2011 | EP2361635A2 Anti IgE vaccines |
| 08/31/2011 | EP2361624A1 Oxazole derivatives and their use as tyrosine kinase inhibitors |
| 08/31/2011 | EP2361513A1 DHA- and EPA-rich nutritional ingredient |
| 08/31/2011 | EP2361248A1 Heteroaryl compounds and uses thereof |
| 08/31/2011 | EP2361096A1 Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue and/or fever |
| 08/31/2011 | EP2361095A1 Antagonists of il-6 to raise albumin and/or lower crp |
| 08/31/2011 | EP2214659B1 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders |
| 08/31/2011 | EP2187915B1 Use of the peptide phpfhlfvy (renin inhibitor) in anti-angiogenic therapy of certain diseases |
| 08/31/2011 | EP1402015B1 A soluble complex comprising a retroviral surface glycoprotein and fkpa or slyd |
| 08/31/2011 | EP1095140B1 Neurotrophic factors |
| 08/31/2011 | CN102171249A Long-acting interferons and derivatives thereof and methods thereof |
| 08/31/2011 | CN102171211A Piperidine derivatives as JAK3 inhibitors |
| 08/31/2011 | CN102171204A 8-substituted isoquinoline derivative and use thereof |
| 08/31/2011 | CN102170898A Compositions and methods for treatment of radiation exposure |
| 08/31/2011 | CN102170897A Vaccine containing amb a 1 for treating allergy to ragweed |
| 08/31/2011 | CN102168074A Recombinant adenovirus and application thereof |
| 08/31/2011 | CN102168043A Lactobacillus paracasei strain LT12 as immunity regulatory agent |
| 08/31/2011 | CN102167753A Preparation method of oat beta-glucan |
| 08/31/2011 | CN102167745A Human monoclonal antibody against IgE, preparation method and purpose thereof |
| 08/31/2011 | CN102167741A Fully human anti-TNF-alpha (Tumor Necrosis Factor-alpha) monoclonal antibody and preparation method as well as application thereof |
| 08/31/2011 | CN102166357A Medicinal composition containing bicyclic aza-alkane derivative |
| 08/31/2011 | CN102166347A New medicinal application of interleukin-12 |
| 08/31/2011 | CN102166306A Dendrobe-lucid ganoderma sianchau active health promotion preparation and preparation method |
| 08/31/2011 | CN102166294A Common anemarrhena polysaccharide extractive and preparation method and medicinal purposes thereof |
| 08/31/2011 | CN102166285A Umbilical plaster for treating allergic skin itching and psoriasis and preparation method thereof |
| 08/31/2011 | CN102166282A Anti-allergic or desensitized pharmaceutical composition |
| 08/31/2011 | CN102166281A Medicated wine for improving immunity, nourishing kidney and strengthening body |
| 08/31/2011 | CN102166269A Method for extracting flavones from waste slags of citrus bergamot drink |
| 08/31/2011 | CN102166254A Oil-in-water type spearmint oil nano emulsion and method for preparing same |
| 08/31/2011 | CN102166248A Rape pollen extract and preparation method and application thereof |
| 08/31/2011 | CN102166245A Oil in water type blumea oil nanoemulsion and preparation method thereof |
| 08/31/2011 | CN102166236A Oil-in-water type notopterygium oil nano emulsion oral liquid and preparation method thereof |
| 08/31/2011 | CN102166233A Oil-in-water type sea buckthorn oil nano-emulsion oral liquid and preparation method thereof |
| 08/31/2011 | CN102166227A Pharmaceutical composition with function of enhancing immunity |
| 08/31/2011 | CN102166220A Bacille calmette-guerin (BCG) immunosuppressant, and preparation method and application thereof |
| 08/31/2011 | CN102166215A Pharmaceutical composition containing piperazine derivatives |
| 08/31/2011 | CN102166214A Medical application of aminothiazole type MyD88 specific inhibitor |
| 08/31/2011 | CN102166207A Application of artemether in preparation of anopheline mosquito immune system inhibitor |
| 08/31/2011 | CN102166201A Oral ciclosporin A sustained-release agent and preparation method thereof |
| 08/31/2011 | CN102166194A Preparation method of anthocyanidin pellet |
| 08/31/2011 | CN102166183A Immunologic stimulant oral syrup and preparation method thereof |
| 08/31/2011 | CN101862342B External medicament for treating dermatophytosis |
| 08/31/2011 | CN101837005B Process for preparing pig placenta extract |
| 08/31/2011 | CN101732371B Co-production extract method of fruit oil and polysaccharide from seabuckthorn fruit paste |
| 08/31/2011 | CN101606964B Veterinary traditional Chinese medical compound preparation |
| 08/31/2011 | CN101549066B Prescription for treating allergy purpura and method for preparing same |
| 08/31/2011 | CN101439147B Haiqihuang granules as well as preparation method thereof and pharmacy use |
| 08/31/2011 | CN101428049B Upper respiratory tract infection resistant medicament composition, preparation and uses thereof |
| 08/31/2011 | CN101401939B Anti-activated state T cell antibody vaccine for preventing and/or treating immune correlated disease |
| 08/31/2011 | CN101367871B Snake venom protein component of ahylysantinfarctase at southern Anhui Province, extraction method and uses thereof |
| 08/31/2011 | CN101204202B Ruminant granular humic acid feed |
| 08/31/2011 | CN101181320B Dyer's woad root vitamin C effervescent formulation |
| 08/31/2011 | CN101099571B Health-care food for strengthening immunity and its preparing method |
| 08/31/2011 | CN101095716B Use of cortex eucommiae total polyoses in the preparing of the medicine for preventing and treating systematic lupus erythematosus |
| 08/31/2011 | CN101068559B Anti-hypersensitive inflammation and anti-allergy activities of zingiber zerumbet (L.) smith |
| 08/31/2011 | CN101062071B Total saponins from radix bupleuri extract and the preparing method thereof |
| 08/30/2011 | US8008341 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases |
| 08/30/2011 | US8008321 Imidazo[1,5-a]pyridin-3-yl)(3-methoxy-4-nitrophenyl)methanone; a and b fibroblast growth factor receptors (FGFR) antagonist; anticarcinogenic, antitumor: lung, breast, prostate, melanomas, gliomas; antiinflammatory, vascular smooth muscle cells: atherosclerosis, restenosis, stent and bypass complications |
| 08/30/2011 | US8008276 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 08/30/2011 | US8008266 Nucleic acids containing unmethylated cytosine-guanine dinucleotides activate lymphocytes and redirect an immune response from th2 to th1 |
| 08/30/2011 | US8008258 Cop 1 for treatment of inflammatory bowel diseases |